A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence

We developed a test to predict which patients will achieve pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and which will have residual disease (RD). Gene expression data from pretreatment biopsies of patients with all breast cancer subtypes were combined into a 519-patient co...

Descripción completa

Detalles Bibliográficos
Autores principales: Fournier, Marcia V., Goodwin, Edward C., Chen, Joan, Obenauer, John C., Tannenbaum, Susan H., Brufsky, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795899/
https://www.ncbi.nlm.nih.gov/pubmed/31619719
http://dx.doi.org/10.1038/s41598-019-51335-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795899/
https://www.ncbi.nlm.nih.gov/pubmed/31619719
http://dx.doi.org/10.1038/s41598-019-51335-1

Ejemplares similares